期刊文献+

急性ST段抬高型心肌梗死经皮冠状动脉介入术后患者发生心肌微循环灌注障碍的影响因素分析及风险预测模型的构建

Analysis of influencing factors and construction of risk prediction model for myocardial microcirculation perfusion disorders in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention
下载PDF
导出
摘要 目的 分析急性ST段抬高型心肌梗死(STEMI)经皮冠状动脉介入术(PCI)后患者发生心肌微循环灌注障碍的影响因素,并构建风险预测模型。方法 回顾2020年5月~2024年1月于唐山市妇幼保健院行PCI的384例STEMI患者的临床资料,并采用随机数字表法分为建模组(n=269)和验证组(n=115)。根据建模组患者术后TIMI心肌灌注分级(TMPG)分为障碍组(n=61)和正常组(n=208)。STEMI患者PCI后心肌微循环障碍的影响因素采用多因素logistic回归分析;构建预测STEMI患者PCI后心肌微循环障碍的列线图预测模型,绘制校准曲线和ROC曲线评估模型预测效能。结果 与正常组比较,障碍组左心室射血分数(LVEF)较低,糖尿病、高血压、症状-首次医疗接触(FMC)>4 h、FMC-肝素给予(H)>4 h、冠状动脉慢血流的占比较高(P<0.05)。多因素logistic回归分析显示,LVEF(OR=0.875)、糖尿病(OR=2.284)、高血压(OR=2.417)、症状-FMC时间(OR=3.200)、FMC-H时间(OR=2.185)、冠状动脉慢血流(OR=2.416)均为STEMI患者PCI后心肌微循环灌注障碍的影响因素(P<0.05)。建模组ROC曲线下面积为0.820(95%CI 0.761~0.880),敏感度为72.13%,特异度为80.77%;验证组ROC曲线下面积为0.899(95%CI 0.814~0.984),敏感度为90.00%,特异度为80.00%。Hosmer-Lemeshow拟合度检验中,建模组χ^(2)=11.877,P=0.157,验证组χ^(2)=10.438,P=0.236。结论 STEMI患者PCI后心肌微循环灌注障碍的发生与LVEF、糖尿病、高血压、症状-FMC时间、FMC-H时间、冠状动脉慢血流密切相关,基于这些因素构建的风险预测模型区分度较佳。 Objective To analyze the influencing factors of myocardial microcirculation perfusion disorders in patients with acute ST segment elevation myocardial infarction(STEMI)after percutaneous coronary intervention(PCI)and to construct a risk prediction model.Methods The clinical data of 384 STEMI patients who underwent PCI in Tangshan Maternal and Child Health Hospital from May 2020 to January 2024 were reviewed and divided into the modeling group(n=269)and verification group(n=115)by random number table method.According to the postoperative TIMI myocardial perfusion grading(TMPG)of patients in the modeling group,they were separated into the obstacle group(n=61)and the normal group(n=208).The influencing factors of myocardial microcirculation disturbance after PCI in STEMI patients were analyzed by multivariate logistic regression.A nematographic prediction model for predicting myocardial microcirculation disturbance in STEMI patients after PCI was constructed,and the calibration curve and ROC curve were drawn to evaluate the prediction efficiency of the model.Results Compared with the normal group,the left ventricular ejection fraction(LVEF)in the obstacle group was lower but the proportions of diabetes,hypertension,symptom first medical contact(FMC)>4 h,FMC heparin(H)>4 h,and coronary slow flow were higher(P<0.05).Multivariate logistic regression found that LVEF(OR=0.875),diabetes(OR=2.284),hypertension(OR=2.417),symptom-FMC time(OR=3.200),FMC-H time(OR=2.185)and coronary slow flow(OR=2.416)were all the influencing factors of myocardial microcirculation perfusion obstruction in STEMI patients after PCI(P<0.05).The area under the ROC curve of the modeling group was 0.820(95%CI 0.761-0.880),with a sensitivity of 72.13%and a specificity of 80.77%;the area under the ROC curve of the validation group was 0.899(95%CI 0.814-0.984),with a sensitivity of 90.00%and a specificity of 80.00%.In the Hosmer-Lemeshow fit test,the modeling groupχ^(2)=11.877,P=0.157,and the validation groupχ^(2)=10.438,P=0.236.Conclusion The occurr
作者 王静 刘树凯 张丽 凡艳儒 王海山 WANG Jing;LIU Shu-kai;ZHANG Li;FAN Yan-ru;WANG Hai-shan(Center,Tangshan Maternal and Child Health Hospital,Tangshan 063000,China;Internal Medicine,Tangshan Maternal and Child Health Hospital,Tangshan 063000,China)
出处 《中国心血管病研究》 CAS 2024年第6期543-548,共6页 Chinese Journal of Cardiovascular Research
基金 河北省医学科学研究重点课题计划项目(20221765)。
关键词 急性ST段抬高型心肌梗死 经皮冠状动脉介入术 心肌微循环灌注障碍 影响因素 预测模型 Acute ST segment elevation myocardial infarction Percutaneous coronary intervention Myocardial microcirculation perfusion disorders Influencing factors Prediction model
  • 相关文献

参考文献9

二级参考文献116

  • 1王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:138
  • 2Menees DS, Peterson ED, Wang Y, et al. Door-to-ballon time and mortality among patients undergoing primary PCI [ J ]. N Engl J Med, 2013, 369 ( 10 ) : 901-909. 被引量:1
  • 3Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-segment Elevation of European Society of Cardiology (ESC) [J]. Eur Heart J, 2016, 37 (3): 267-315. 被引量:1
  • 4Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE- Retrospective Acute Myocardial infarction Study) : a retrospective analysis of hospital data [J]. Lancet, 2015, 385 (9966): 441- 451. 被引量:1
  • 5O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guideline [ J]. Circulation, 2013, 127 ( 4 ) : e362-425. 被引量:1
  • 6MeNamara RL, Herrin J, Wang Y, et al. Impact of delay in door- to-needle time on mortality in patients with ST-segment elevation myocardial infarction [J]. Am J Cardiol, 2007, 100 (8) : 1227- 1232. 被引量:1
  • 7Widimsky P, Budesinsky T, Vorae D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multieentretrial-PRAGUE-2 [ J]. Eur Heart J, 2003, 24 (1) : 94-104. 被引量:1
  • 8Han YL, Liu JN, Jing QM, et al. The Efficacy and Safety of Pharmacoinvasive Therapy with Prourokinase for Acute ST-Segment Elevation Myocardial Infarction Patients with Expected Long Percutaneous Coronary Intervention-Related Delay [ J]. Cardiovasc Ther, 2013, 31 ( 5 ) : 285-290. 被引量:1
  • 9Danchin N, Coste P, Ferrieres J, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST- devation myocardial infarction (FAST-MI) [J]. Circulation, 2008, 118 (3) : 268-276. 被引量:1
  • 10Bhatl NS, Solhpour A, Balan P , et al. Comparison of in-hospital outcomes with low-dose fibrionlytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary infarction alone for treatment of ST-elevation myocardial infarction [J]. Am J Cardion, 2013, 111 (11): 1576-1579. 被引量:1

共引文献1922

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部